483
Shannon R. Schrader, M.D.FDA 483 - Shannon R. Schrader, M.D. - March 03, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Research Access Network in Houston, TX, was cited for significant deficiencies in its clinical trial conduct. Observations included failures to follow the investigator's statement regarding subject procedures and visits, inadequate investigational drug disposition records, and a critical failure to obtain proper informed consent from human subjects. These issues indicate a lack of adherence to study protocols and regulatory requirements.
Open in Dashboard
ID · 0cb83a09-4aeb-45a8-9be8-a7449a7fbe8c